Product image of Gática (Pregabalin) supplied by GNH India

Gática

Active Ingredient:
Pregabalin
Origin:
EU

Gática (Pregabalin)

Gática is a prescription medication that contains the active ingredient pregabalin, supplied as an oral formulation. It belongs to the gabapentinoid class and is marketed in the European Union. Pregabalin works by binding to the α2δ subunit of voltage‑gated calcium channels, which helps modulate neurotransmitter release. Gática is used under medical supervision for several neurological and pain‑related conditions, including neuropathic pain, partial seizures, generalized anxiety disorder, and fibromyalgia.

Manufacturer / TM Owner

Laboratorios Alter, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gática (pregabalin) is prescribed for several conditions that involve abnormal nerve signaling or heightened neuronal excitability.

  • Neuropathic pain associated with diabetic peripheral neuropathy or post‑herpetic neuralgia.
  • Partial seizures in patients with epilepsy as adjunctive therapy.
  • Generalized anxiety disorder when other treatments are insufficient.
  • Fibromyalgia to reduce widespread musculoskeletal pain.
  • Adjunctive treatment for spinal cord injury–related pain.

Side Effects

Side effects of Gática vary in frequency and severity; they are reported in clinical studies and post‑marketing surveillance.

Common

  • Dizziness or light‑headedness.
  • Somnolence or increased sleepiness.
  • Peripheral edema, especially in the lower extremities.
  • Weight gain.
  • Blurred vision or visual disturbances.
  • Dry mouth.
  • Difficulty concentrating.

Serious

  • Angioedema or severe swelling of the face, lips, or throat.
  • Severe skin reactions such as Stevens‑Johnson syndrome.
  • Suicidal thoughts or behavior.
  • Respiratory depression, particularly when combined with other CNS depressants.
  • Cardiac arrhythmias.
  • Severe hypotension.

Precautions & Warnings

Before starting Gática, clinicians should evaluate several safety considerations to minimize risk.

  • Assess renal function because dosage may need adjustment in impairment.
  • Review history of substance misuse, as pregabalin has potential for dependence.
  • Monitor for signs of depression or suicidal ideation, especially in younger adults.
  • Use caution in pregnancy; discuss potential risks with a healthcare provider.
  • Avoid abrupt discontinuation to prevent withdrawal symptoms.
  • Evaluate for cardiovascular disease if edema or hypertension is present.

Avoid Interactions

Gática can interact with other medicines, affecting its efficacy or safety profile.

Avoid

  • Opioids or other central nervous system depressants, which may increase sedation and respiratory depression.
  • Antihistamines or benzodiazepines that enhance drowsiness.
  • Certain antiepileptic drugs that may alter pregabalin levels (e.g., carbamazepine).

Use with caution

  • ACE inhibitors or ARBs, as combined use may worsen peripheral edema.
  • Diuretics, which can affect fluid balance.
  • Alcohol, due to additive CNS depressant effects.

Frequently Asked Questions

Gática is indicated for neuropathic pain, partial seizures in epilepsy, generalized anxiety disorder, and fibromyalgia, and may be used for related pain conditions.

Pregabalin binds to the α2δ subunit of voltage‑gated calcium channels, reducing the release of excitatory neurotransmitters that contribute to pain signaling.

Gática may be prescribed for generalized anxiety disorder when first‑line therapies are ineffective or not tolerated, but treatment decisions are individualized.

Common adverse effects include dizziness, somnolence, peripheral edema, weight gain, blurred vision, dry mouth, and difficulty concentrating.

Serious reactions such as angioedema, severe skin rash (e.g., Stevens‑Johnson syndrome), suicidal thoughts, respiratory depression, cardiac arrhythmias, or severe hypotension should prompt urgent medical care.

Renal impairment can affect pregabalin clearance; dosage adjustments or increased monitoring are recommended for patients with reduced kidney function.

Pregabalin has potential for misuse and dependence, especially in individuals with a history of substance abuse, so clinicians should assess risk before initiating therapy.

Concomitant use of opioids, other CNS depressants, antihistamines, benzodiazepines, and certain antiepileptics like carbamazepine should be avoided due to increased sedation and interaction risk.

Alcohol can enhance the central nervous system depressant effects of Gática, leading to increased drowsiness, dizziness, and impaired coordination.

Regular assessment of renal function, weight, edema, mood changes, and signs of suicidal ideation is advised during treatment.

Abrupt discontinuation may lead to withdrawal symptoms such as insomnia, nausea, headache, and anxiety; tapering the dose under medical supervision is recommended.

The safety of Gática during pregnancy has not been fully established; it should only be used if the potential benefit justifies the potential risk to the fetus.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.